CALGB/SWOG – C80405 – A Phase III Trial of Irinotecan/5-FU/Leucovorin or Oxaliplatin/5-FU/Leucovorin with Bevacizumab, or Cetuximab (C225) for Patients with Untreated Metatastic Adenocarcinoma of the Colon or Rectum (Note: This new study title reflects removal of Arm C.)

Clinical Trial Categories

  • Colorectal Cancer
Contact
The Rosenfeld Cancer Center at 215-481-2402

Location

  • The Rosenfeld Cancer Center